机构:[1]Laboratory of Anaesthesiology & Critical Care Medicine, Department of Anesthesiology, State Key Laboratory of Biotherapy and Cancer Center and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[2]Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, PR China四川大学华西医院
National Natural Science Foundation of China (22307089), the Post-Doctoral Research Project of West China Hospital, Sichuan University (2021HXBH038), and the Sichuan University Postdoctoral Interdisciplinary Innovation Fund.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|4 区医学
小类|2 区有机化学4 区药物化学
最新[2023]版:
大类|4 区医学
小类|2 区有机化学4 区药物化学
第一作者:
第一作者机构:[1]Laboratory of Anaesthesiology & Critical Care Medicine, Department of Anesthesiology, State Key Laboratory of Biotherapy and Cancer Center and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Laboratory of Anaesthesiology & Critical Care Medicine, Department of Anesthesiology, State Key Laboratory of Biotherapy and Cancer Center and Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China[2]Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu, PR China
推荐引用方式(GB/T 7714):
Ai Wei,Zuo Zeping.Synthesis, optimization and antitumor activity evaluation of sulfonyl benzoyl hydrazide derivatives as novel human LSD1 inhibitors[J].Bioorganic & Medicinal Chemistry Letters.2024,114:129982.doi:10.1016/j.bmcl.2024.129982.
APA:
Ai Wei&Zuo Zeping.(2024).Synthesis, optimization and antitumor activity evaluation of sulfonyl benzoyl hydrazide derivatives as novel human LSD1 inhibitors.Bioorganic & Medicinal Chemistry Letters,114,
MLA:
Ai Wei,et al."Synthesis, optimization and antitumor activity evaluation of sulfonyl benzoyl hydrazide derivatives as novel human LSD1 inhibitors".Bioorganic & Medicinal Chemistry Letters 114.(2024):129982